TN2011000471A1 - Pharmaceutical composition presenting anti-inflammatory properties - Google Patents

Pharmaceutical composition presenting anti-inflammatory properties

Info

Publication number: TN2011000471A1
Authority: TN; Tunisia
Prior art keywords: pharmaceutical composition; inflammatory properties; composition presenting; presenting anti; composition
Prior art date: 2009-03-20

Application number

TN2011000471A

Other languages

English (en)

Inventor

Fabian Priem

Ingrid Jacquemond-Collet

Original Assignee

Bioxtract S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-20

Filing date

2011-09-19

Publication date

2013-03-27

2011-09-19 Application filed by Bioxtract S A filed Critical Bioxtract S A

2013-03-27 Publication of TN2011000471A1 publication Critical patent/TN2011000471A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TN2011000471A 2009-03-20 2011-09-19 Pharmaceutical composition presenting anti-inflammatory properties TN2011000471A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP09155800		2009-03-20
EP09181041		2009-12-31
PCT/EP2010/053719 WO2010106191A1 (fr)	2009-03-20	2010-03-22	Composition pharmaceutique à propriétés anti-inflammatoires

Publications (1)

Publication Number	Publication Date
TN2011000471A1 true TN2011000471A1 (en)	2013-03-27

Family

ID=42235834

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TN2011000471A TN2011000471A1 (en)	2009-03-20	2011-09-19	Pharmaceutical composition presenting anti-inflammatory properties

Country Status (10)

Country	Link
EP (1)	EP2408442B1 (fr)
CN (1)	CN102405046B (fr)
AU (1)	AU2010224811B2 (fr)
BR (1)	BRPI1006229A2 (fr)
ES (1)	ES2604127T3 (fr)
MA (1)	MA33220B1 (fr)
MX (1)	MX339414B (fr)
RU (1)	RU2532384C2 (fr)
TN (1)	TN2011000471A1 (fr)
WO (1)	WO2010106191A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013175507A1 (fr) *	2012-05-22	2013-11-28	Laila Pharmaceuticals Pvt. Ltd.	Nouvelles nanoformulations de composés et extraits dérivés de plantes hydrophobes, hautement biodisponibles, solubles dans l'eau et à libération prolongée
DE202012012130U1 (de) *	2012-12-19	2014-03-21	Aquanova Ag	Curcuminsolubilisat
US20140271923A1 (en)	2013-03-14	2014-09-18	Christopher Brian Reid	Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
US9504754B2 (en)	2013-03-15	2016-11-29	South Dakota Board Of Regents	Curcuminoid complexes with enhanced stability, solubility and/or bioavailability
EP2996704B1 (fr) *	2013-05-14	2021-01-06	Mars, Incorporated	Composition de soin des articulations
WO2015025263A1 (fr) *	2013-08-19	2015-02-26	Plant Lipids Private Limited	Nouvelle composition de curcumine à biodisponibilité améliorée
KR20150080342A (ko) *	2013-12-31	2015-07-09	삼성정밀화학 주식회사	기능성 음료
EP3009013B1 (fr) *	2014-09-16	2018-12-12	Alfasigma S.p.A.	Compositions nutritionnelles et thérapeutiques pour le traitement du syndrome du côlon irritable
AU2015330851B2 (en)	2014-10-08	2022-10-13	Boston Biopharm, Inc.	Compositions and methods for increasing the bioavailability of one or more compounds
US11318110B2 (en)	2015-08-28	2022-05-03	Caliway Biopharmaceuticals Co., Ltd.	Pharmaceutical composition for reducing local fat and uses thereof
EP3381451B1 (fr)	2015-08-28	2025-08-20	Caliway Biopharmaceuticals Co., Ltd.	Composition pharmaceutique utilisée pour réduire la graisse localisée et utilisation de la composition pharmaceutique
RU2654868C1 (ru) *	2017-03-10	2018-05-23	Сергей Иванович Корнилов	Нутрицевтическая композиция
BE1026269B1 (fr) *	2018-05-09	2019-12-10	Tilman Sa	Formulation à propriétés anti-inflammatoires
CN109223738A (zh) *	2018-10-16	2019-01-18	常州大学	脂质体二甲基姜黄素抑制二肽肽酶i和基质金属蛋白酶9活性
BE1026902B1 (fr)	2018-12-20	2020-07-22	Farmafyt	Médicament et complément alimentaire contre des troubles gynécologiques
TR201910337A2 (tr) *	2019-07-10	2021-01-21	Mehmet Nevzat Pisak	Yüksek çözünürlüğe ve bi̇yoyararlanima sahi̇p kurkumi̇noi̇d oral bi̇leşi̇mleri̇
CN111265503B (zh) *	2020-03-25	2021-03-12	广东工业大学	一种抑制5α-还原酶活性的组合物及其应用
WO2021201264A1 (fr) *	2020-04-02	2021-10-07	株式会社セラバイオファーマ	Composition pharmaceutique pour administration parentérale pour le traitement, la prévention ou le soulagement de l'arthrose
CN116113405A (zh) *	2020-08-21	2023-05-12	L·曼恩特托马斯	用于预防或治疗病毒感染的药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4263333A (en) *	1979-09-12	1981-04-21	General Foods Corporation	Curcumin-metal color complexes
KR20020073847A (ko) *	2001-03-16	2002-09-28	주식회사 바이오시너젠	쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물
CN1274300C (zh) *	2003-12-11	2006-09-13	中国科学院生物物理研究所	用于改善姜黄素溶出度和生物利用度的药物组合物及其制备方法
JP4206923B2 (ja) *	2003-12-26	2009-01-14	三栄源エフ・エフ・アイ株式会社	水性ウコン色素製剤の調製方法
CN100486567C (zh) *	2004-08-12	2009-05-13	山东绿叶天然药物研究开发有限公司	姜黄素乳剂及其制备方法
US20060045928A1 (en) *	2004-08-31	2006-03-02	Seiri Oshiro	Composition containing herbal medicine component for promoting absorption and production method thereof
CN100352430C (zh) *	2005-03-09	2007-12-05	山东大学	姜黄素自微乳化制剂及其制备方法
US20060275516A1 (en)	2005-06-02	2006-12-07	Ram A N S	Compositions and methods for the treatment of allergic rhinitis
EP1993365B1 (fr) *	2006-03-06	2013-05-08	The Regents of the University of California	Formulations de curcuminoïde biodisponibles pour traiter la maladie d'alzheimer et d'autres troubles associés à l'âge
EP1837030A1 (fr)	2006-03-09	2007-09-26	INDENA S.p.A.	Complexes phospholipidiques de curcumin ayant une biodisponibilité améliorée
CN1895239B (zh) *	2006-06-20	2010-05-12	中国人民解放军第二军医大学	一种姜黄素制剂及其制备方法
CN101361713B (zh) *	2008-09-08	2010-08-25	山东大学	姜黄素纳米结晶制剂的制备方法

2010
- 2010-03-22 EP EP10715741.4A patent/EP2408442B1/fr active Active
- 2010-03-22 AU AU2010224811A patent/AU2010224811B2/en not_active Ceased
- 2010-03-22 MA MA34281A patent/MA33220B1/fr unknown
- 2010-03-22 RU RU2011138101/15A patent/RU2532384C2/ru not_active IP Right Cessation
- 2010-03-22 WO PCT/EP2010/053719 patent/WO2010106191A1/fr not_active Ceased
- 2010-03-22 CN CN201080017578.8A patent/CN102405046B/zh not_active Expired - Fee Related
- 2010-03-22 BR BRPI1006229A patent/BRPI1006229A2/pt not_active IP Right Cessation
- 2010-03-22 MX MX2011009785A patent/MX339414B/es active IP Right Grant
- 2010-03-22 ES ES10715741.4T patent/ES2604127T3/es active Active
2011
- 2011-09-19 TN TN2011000471A patent/TN2011000471A1/fr unknown

Also Published As

Publication number	Publication date
CN102405046A (zh)	2012-04-04
AU2010224811B2 (en)	2015-07-16
MX339414B (es)	2016-05-24
RU2532384C2 (ru)	2014-11-10
AU2010224811A1 (en)	2011-10-13
ES2604127T3 (es)	2017-03-03
EP2408442A1 (fr)	2012-01-25
RU2011138101A (ru)	2013-04-27
WO2010106191A1 (fr)	2010-09-23
CN102405046B (zh)	2014-07-02
EP2408442B1 (fr)	2016-08-17
BRPI1006229A2 (pt)	2016-02-10
MA33220B1 (fr)	2012-04-02
MX2011009785A (es)	2012-01-12

Publication	Publication Date	Title
TN2011000471A1 (en)	2013-03-27	Pharmaceutical composition presenting anti-inflammatory properties
WO2011086093A3 (fr)	2012-05-24	Compositions pharmaceutiques pour l'administration orale de peptides de l'insuline
MY167918A (en)	2018-09-27	Composition for use in the sublingual delivery of medicaments to humans
IN2012DN02805A (fr)	2015-07-24
WO2011131943A8 (fr)	2012-11-29	Compositions pharmaceutiques
GT200900230A (es)	2011-11-29	4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
PH12015501737A1 (en)	2017-04-24	Androgen receptor modulators and uses thereof
MX350088B (es)	2017-08-25	Composicion farmaceutica estable y metodos de uso de la misma.
MX2011002065A (es)	2011-09-01	Composicion farmaceutica a base de progesterona micronizada y sus usos.
EP4414376A3 (fr)	2024-11-06	Nouveau depsipeptide et ses utilisations
MX347734B (es)	2017-05-11	Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
WO2012049307A3 (fr)	2012-06-14	Nouveaux dérivés d'insuline à extrémité n modifiée
CL2012000319A1 (es)	2012-09-14	Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística.
UY33530A (es)	2012-02-29	Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
TN2013000239A1 (en)	2014-11-10	New form of administration of enkephalinase inhibitor
TN2009000510A1 (en)	2011-03-31	Extended release formulation of nevirapine
WO2010090611A3 (fr)	2011-02-03	Compositions pharmaceutiques à l'odeur et au goût masqués hautement biodisponibles
MX2013012918A (es)	2013-11-21	Formulaciones de liberacion sostenida de paracetamol.
MX349563B (es)	2017-08-02	Formulacion farmaceutica de fenofibrato nanonizado.
CO6751242A2 (es)	2013-09-16	Combinación y composición para el tratamiento de obesidad
ECSP13012765A (es)	2013-09-30	Combinación y composición para el tratamiento de obesidad
WO2012044046A3 (fr)	2012-06-07	Nouveaux dérivés de méthylcyclohexane et leurs utilisations
WO2011002425A3 (fr)	2011-03-03	Composition pharmaceutique présentant une solubilité et une stabilité accrues
WO2011002423A3 (fr)	2011-03-03	Composition pharmaceutique augmentant la solubilité
MX345917B (es)	2017-02-16	Composiciones analgesicas que comprenden quercetina mas ketorolaco.